Extracorporeal Shock Wave Lithotripsy Does Not Increase The Risk Of Diabetes

Main Category: Urology / Nephrology
Also Included In: Diabetes
Article Date: 20 Jun 2008 - 1:00 PDT

email to a friend   printer friendly   opinions  

ORLANDO, FL (UroToday.com) - Researchers from the University of Minnesota used a mailed survey to collect data on the presence and onset of diabetes mellitus in 1869 patients treated with SWL using the Medstone STS electrohydraulic lithotriptor.

These patients were matched by age, sex and body mass index to controls from the National Health and Nutrition Examination Survey (NHANES) data base. In the study group 60% of the patients were male, the average age was 52 years at the time of SWL and 58 years at the end of the study. The mean BMI was 29. At the time of SWL 8.7% of patients were diabetes mellitus. This increased to 14% at the time of the survey. In the NHANES group, 8.3% had diabetes mellitus at the time the SWL group underwent treatment, and this increased to 14% at the time of the NHANES survey. Therefore, the rate of new diabetes mellitus cases in the SWL group was the same as that in the NHANES group (5.2% in SWL group versus 5.6% in NHANES group, p=0.07).

Therefore, in six-years follow-up patients treated with SWL did not develop diabetes at a higher rate than the general population.

Presented by Antoine A. Makhlouf, MD, et al., at the Annual Meeting of the American Urological Association (AUA) - May 17 - 22, 2008. Orange County Convention Center - Orlando, Florida, USA.

Reported by UroToday.com Contributing Editor Elspeth M. McDougall, MD, FRCSC

UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.

To access the latest urology news releases from UroToday, go to: www.urotoday.com

Copyright © 2008 - UroToday

• Additional
• References
• Citations